237 related articles for article (PubMed ID: 28476777)
1. Disease Stage-Dependent Changes in Cardiac Contractile Performance and Oxygen Utilization Underlie Reduced Myocardial Efficiency in Human Inherited Hypertrophic Cardiomyopathy.
Güçlü A; Knaapen P; Harms HJ; Parbhudayal RY; Michels M; Lammertsma AA; van Rossum AC; Germans T; van der Velden J
Circ Cardiovasc Imaging; 2017 May; 10(5):. PubMed ID: 28476777
[TBL] [Abstract][Full Text] [Related]
2. Myocardial adaptation after surgical therapy differs for aortic valve stenosis and hypertrophic obstructive cardiomyopathy.
Parbhudayal RY; Güçlü A; Zweerink A; Biesbroek PS; Croisille P; Clarysse P; Michels M; Stooker W; Vonk ABA; van der Ven PM; van Rossum AC; van der Velden J; Nijveldt R
Int J Cardiovasc Imaging; 2019 Jun; 35(6):1089-1100. PubMed ID: 30825136
[TBL] [Abstract][Full Text] [Related]
3. Increased Myocardial Oxygen Consumption Precedes Contractile Dysfunction in Hypertrophic Cardiomyopathy Caused by Pathogenic
Parbhudayal RY; Harms HJ; Michels M; van Rossum AC; Germans T; van der Velden J
J Am Heart Assoc; 2020 Apr; 9(8):e015316. PubMed ID: 32290750
[TBL] [Abstract][Full Text] [Related]
4. Myocardial efficiency is an important determinant of functional improvement after aortic valve replacement in aortic valve stenosis patients: a combined PET and CMR study.
Güçlü A; Knaapen P; Harms HJ; Vonk AB; Stooker W; Groepenhoff H; Lammertsma AA; van Rossum AC; Germans T; van der Velden J
Eur Heart J Cardiovasc Imaging; 2015 Aug; 16(8):882-9. PubMed ID: 25680386
[TBL] [Abstract][Full Text] [Related]
5. Myocardial Oxygen Consumption and Efficiency in Aortic Valve Stenosis Patients With and Without Heart Failure.
Hansson NH; Sörensen J; Harms HJ; Kim WY; Nielsen R; Tolbod LP; Frøkiær J; Bouchelouche K; Dodt KK; Sihm I; Poulsen SH; Wiggers H
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28167498
[TBL] [Abstract][Full Text] [Related]
6. Myocardial mechanical remodeling after septal myectomy for severe obstructive hypertrophic cardiomyopathy.
Moravsky G; Bruchal-Garbicz B; Jamorski M; Ralph-Edwards A; Gruner C; Williams L; Woo A; Yang H; Laczay B; Rakowski H; Carasso S
J Am Soc Echocardiogr; 2013 Aug; 26(8):893-900. PubMed ID: 23800507
[TBL] [Abstract][Full Text] [Related]
7. Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations.
Witjas-Paalberends ER; Güçlü A; Germans T; Knaapen P; Harms HJ; Vermeer AM; Christiaans I; Wilde AA; Dos Remedios C; Lammertsma AA; van Rossum AC; Stienen GJ; van Slegtenhorst M; Schinkel AF; Michels M; Ho CY; Poggesi C; van der Velden J
Cardiovasc Res; 2014 Jul; 103(2):248-57. PubMed ID: 24835277
[TBL] [Abstract][Full Text] [Related]
8. Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction.
Timmer SA; Germans T; Brouwer WP; Lubberink M; van der Velden J; Wilde AA; Christiaans I; Lammertsma AA; Knaapen P; van Rossum AC
Eur J Heart Fail; 2011 Dec; 13(12):1283-9. PubMed ID: 22021246
[TBL] [Abstract][Full Text] [Related]
9. Determinants of myocardial energetics and efficiency in symptomatic hypertrophic cardiomyopathy.
Timmer SA; Germans T; Götte MJ; Rüssel IK; Dijkmans PA; Lubberink M; ten Berg JM; ten Cate FJ; Lammertsma AA; Knaapen P; van Rossum AC
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):779-88. PubMed ID: 20069294
[TBL] [Abstract][Full Text] [Related]
10. Microvascular Rarefaction and Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy.
Tian H; Yang C; Song Y; Wang H; Yuan J; Cui J; Liu S; Hu F; Yang W; Jiang X; Qiao S
Cardiology; 2018; 141(4):202-211. PubMed ID: 30820009
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical and echocardiographic outcomes of extensive septal myectomy for hypertrophic obstructive cardiomyopathy in Chinese patients.
Yao L; Li L; Lu XJ; Miao YL; Kang XN; Duan FJ
Cardiovasc Ultrasound; 2016 May; 14(1):18. PubMed ID: 27189485
[TBL] [Abstract][Full Text] [Related]
12. Surgery of Hypertrophic Obstructive Cardiomyopathy in Patients With Severe Hypertrophy, Myocardial Fibrosis, and Ventricular Tachycardia.
Borisov KV
Ann Thorac Surg; 2018 Jul; 106(1):30-37. PubMed ID: 29534954
[TBL] [Abstract][Full Text] [Related]
13. Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy.
Timmer SA; Knaapen P; Germans T; Dijkmans PA; Lubberink M; Ten Berg JM; Ten Cate FJ; Rüssel IK; Götte MJ; Lammertsma AA; van Rossum AC
Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H129-37. PubMed ID: 21490327
[TBL] [Abstract][Full Text] [Related]
14. Predictors of exercise capacity following septal myectomy in patients with hypertrophic cardiomyopathy.
Smith JR; Layrisse V; Medina-Inojosa JR; Berg JD; Ommen SR; Olson TP
Eur J Prev Cardiol; 2020 Jul; 27(10):1066-1073. PubMed ID: 31967491
[TBL] [Abstract][Full Text] [Related]
15. ENerGetIcs in hypertrophic cardiomyopathy: traNslation between MRI, PET and cardiac myofilament function (ENGINE study).
Güçlü A; Germans T; Witjas-Paalberends ER; Stienen GJ; Brouwer WP; Harms HJ; Marcus JT; Vonk AB; Stooker W; Yilmaz A; Klein P; Ten Berg JM; Kluin J; Asselbergs FW; Lammertsma AA; Knaapen P; van Rossum AC; van der Velden J
Neth Heart J; 2013 Dec; 21(12):567-71. PubMed ID: 24114686
[TBL] [Abstract][Full Text] [Related]
16. [Early postoperative changes in systolic and diastolic function at rest and during stress in patients with hypertrophic obstructive cardiomyopathy (HOCM) after myectomy].
Schwartzkopff B; Stark P; Schulte HD; Mundhenke M; Klein RM; Lösse B; Vester EG; Strauer BE
Z Kardiol; 1997 Jun; 86(6):438-49. PubMed ID: 9324875
[TBL] [Abstract][Full Text] [Related]
17. Surgical pathology of subaortic septal myectomy: histology skips over clinical diagnosis.
Abecasis J; Gouveia R; Castro M; Andrade MJ; Ribeiras R; Ramos S; Abecasis M; Cardim N; Gil V
Cardiovasc Pathol; 2018; 33():32-38. PubMed ID: 29414430
[TBL] [Abstract][Full Text] [Related]
18. [Dysplastic intramyocardial arteries with subaortic septum in patients with hypertrophic obstructive cardiomyopathy].
Schwartzkopff B; Dieckerhoff J; Frenzel H; Schulte HD; Lösse B; Motz W; Hort W; Strauer BE
Z Kardiol; 1992 Aug; 81(8):456-63. PubMed ID: 1413956
[TBL] [Abstract][Full Text] [Related]
19. Coronary microvascular function, myocardial metabolism, and energetics in hypertrophic cardiomyopathy: insights from positron emission tomography.
Timmer SA; Knaapen P
Eur Heart J Cardiovasc Imaging; 2013 Feb; 14(2):95-101. PubMed ID: 23152441
[TBL] [Abstract][Full Text] [Related]
20. Septal ablation in hypertrophic obstructive cardiomyopathy improves systolic myocardial function in the lateral (free) wall: a follow-up study using CMR tissue tagging and 3D strain analysis.
van Dockum WG; Kuijer JP; Götte MJ; Ten Cate FJ; Ten Berg JM; Beek AM; Twisk JW; Marcus JT; Visser CA; van Rossum AC
Eur Heart J; 2006 Dec; 27(23):2833-9. PubMed ID: 17098761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
